» Articles » PMID: 37594274

Phage ICP3 Requires O1 Antigen for Infection

Overview
Journal Infect Immun
Date 2023 Aug 18
PMID 37594274
Authors
Affiliations
Soon will be listed here.
Abstract

In its natural aquatic environment, the bacterial pathogen , the causative agent of the enteric disease cholera, is in constant competition with bacterial viruses known as phages. Following ICP3 infection, cultures that exhibited phage killing always recovered overnight, and clones isolated from these regrowth populations exhibited complete resistance to subsequent infections. Whole-genome sequencing of these resistant mutants revealed seven distinct mutations in genes encoding for enzymes involved in O1 antigen biosynthesis, demonstrating that the O1 antigen is a previously uncharacterized putative receptor of ICP3. To further elucidate the specificity of the resistance conferred by these mutations, they were challenged with the -specific phages ICP1 and ICP2. All seven O1 antigen mutants demonstrated pan-resistance to ICP1 but not ICP2, which utilizes the OmpU outer membrane protein as a receptor. We show that resistant mutations to ICP1 and ICP3 evolve at a significantly higher frequency than ICP2, but these mutations have a significant fitness tradeoff to and are unable to evolve in the presence of an antimicrobial that mimics host cell defensins.

Citing Articles

A anti-phage system depletes nicotinamide adenine dinucleotide to restrict virulent bacteriophages.

Woldetsadik Y, Lazinski D, Camilli A mBio. 2024; 15(11):e0245724.

PMID: 39377576 PMC: 11559045. DOI: 10.1128/mbio.02457-24.


A Anti-Phage System Depletes Nicotinamide Adenine Dinucleotide to Restrict Virulent Bacteriophages.

Woldetsadik Y, Lazinski D, Camilli A bioRxiv. 2024; .

PMID: 38948830 PMC: 11212891. DOI: 10.1101/2024.06.17.599363.


Special Collection on the 28th Annual Midwest Microbial Pathogenesis Conference.

Sauer J, Mandel M Infect Immun. 2024; 92(4):e0007124.

PMID: 38483162 PMC: 11003223. DOI: 10.1128/iai.00071-24.

References
1.
Dunn A, Millikan D, Adin D, Bose J, Stabb E . New rfp- and pES213-derived tools for analyzing symbiotic Vibrio fischeri reveal patterns of infection and lux expression in situ. Appl Environ Microbiol. 2006; 72(1):802-10. PMC: 1352280. DOI: 10.1128/AEM.72.1.802-810.2006. View

2.
Seed K, Faruque S, Mekalanos J, Calderwood S, Qadri F, Camilli A . Phase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1. PLoS Pathog. 2012; 8(9):e1002917. PMC: 3441752. DOI: 10.1371/journal.ppat.1002917. View

3.
Seed K, Lazinski D, Calderwood S, Camilli A . A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature. 2013; 494(7438):489-91. PMC: 3587790. DOI: 10.1038/nature11927. View

4.
Rodriguez-Gonzalez R, Leung C, Chan B, Turner P, Weitz J . Quantitative Models of Phage-Antibiotic Combination Therapy. mSystems. 2020; 5(1). PMC: 7002117. DOI: 10.1128/mSystems.00756-19. View

5.
Ganesan D, Gupta S, Legros D . Cholera surveillance and estimation of burden of cholera. Vaccine. 2019; 38 Suppl 1:A13-A17. DOI: 10.1016/j.vaccine.2019.07.036. View